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It has recently been shown that an idiotypic determinant(s)  (460-Id) 1 found on the 
2,4-dinitrophenyl (DNP)  and 2,4,6-trinitrophenyl (TNP)-binding myeloma protein, 
MOPC-460,  is expressed on some anti-TNP antibodies produced by BALB/c mice 
after immunization with certain thymus-independent (TI) (1) and thymus-dependent 
(2) TNP antigens. In vitro studies indicate that the 460-Id-bearing component of the 
anti-TNP response to the TI antigen, TNP-Nocardia water-soluble mitogen (NWSM), 
is  regulated  by  a  460-Id-specific suppressor  T  cell  found  in  the  spleen  of normal 
BALB/c mice (1). 
In this communication, we report the results of experiments in which we studied 
the effect of anti-460-Id antibodies and ofanti-[anti-460-Id] antibodies on the response 
to  two  TI  TNP  antigens.  Mice  actively  immunized  with  MOPC-460  or  acutely 
pretreated with anti-460-Id antibodies made an anti-TNP response to TNP-NWSM 
and  to TNP-levan which  lacked  a  460-Id + component.  By contrast,  mice actively 
immunized with purified anti-460-Id antibodies or acutely pretreated with anti-[anti- 
460-Id] antibodies showed an increase in the 460-Id  + component of their anti-TNP 
response. Furthermore, T  cells from mice immunized to anti-460-Id antibodies failed 
to suppress, in vitro, the 460-Id  + component of the response of normal B cells to TNP- 
NWSM.  These  results  suggest  (a)  that  460-Id-specific suppressor T  cells  normally 
regulate in vivo responses to TI TNP-antigens;  (b) that anti-[anti-460-Id] antibodies 
can eliminate 460-Id-specific suppressor T cells; and (c) that 460-Id-specific suppressor 
T  cells and anti-460-Id antibodies share idiotypic determinants. 
Materials and Methods 
Mice.  BALB/cAnN mice,  8-12  wk  old,  were  obtained  from  the  Division of  Research 
Services, National Institutes of Health, Bethesda. Md. 
Antigens.  2,4,6-trinitrophenyl (TNP)-Nocardia water soluble mitogen (NWSM)  was  pre- 
I Abbreviations  used in this paper: AECM, aminoethylcarbamylmethyl; C, complement; HA, hemagglutinin 
titer; Id, idiotype; KLH, keyhole limpet hemocyanin; LPS, lipopolysaccharide; NWSM, Nocardia water 
soluble mitogen; PFC, plaque-forming cell; RIA, radioimrnunoassay; SRBC, sheep erythrocytes; TI, 
thymus-independent; TNP, 2,4,6-trinitrophenyl. 
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pared as previously described (1). An aminoethylcarbamylmethyl (AECM) derivative of levan, 
derived from Aerobacter levanicum, was the kind gift of Dr. C. Glaudemans, National Institute of 
Arthritis, Metabolic and  Digestive Diseases, National Institutes of Health, Bethesda, Md.  It 
contained  1 AECM group per 21  sugars. TNP-levan, containing  1 TNP  per 24 sugars, was 
prepared by the reaction of trinitrobenzenesulfonate with AECM-levan. 
Myeloma Proteins.  MOPC-460,  an  IgA, x-myeloma protein with DNP- and TNP-binding 
activity, and  EPC-109  and UPC-61,  IgA, K-myeloma proteins with fl(2-6), fl(2-1) fructosan- 
binding  activity were  kindly  donated  by  Dr.  Michael  Potter,  National  Cancer  Institute, 
National Institutes of Health, Bethesda, Md. 
Preparation of Anti-Idiotype Antibodies.  Anti-460-Id antibodies were prepared by immunization 
of BALB/c mice with 75/.tg of MOPC-460 myeloma protein emulsified in complete Freund's 
adjuvant. This was  followed 5  d  later by a  similar dose of myeloma protein in  incomplete 
Freund's adjuvant and then by six weekly injections of 75/~g of protein in saline. Anti-460-Id 
antibodies were also obtained from a hybridoma [No. 77-14-11-F6(51)] derived by Buttin et al. 
(3). These antibodies were used in the radioimmunoassay for 460-Id. Antibodies specific for the 
idiotypic determinants of anti-460-Id antibodies (anti-[anti-460-Id] antibodies) were produced 
by immunization of BALB/c mice with  purified anti-460-Id antibodies coupled  to  keyhole 
limpet hemocyanin (KLH). Anti-460-Id antibodies were purified by absorption of an ammo- 
nium  sulfate fraction of BALB/c anti-460-Id serum  to a  Sepharose 4B-MOPC-460  column 
(Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.)  followed by elution 
with a glycine-HC1 buffer (0.1 M; pH 2.8). The purified antibodies were conjugated to KLH 
by mixing purified antibody with KLH, at a final concentration of 0.5 mg/ml, in the presence 
of 0.05% glutaraldehyde. The reaction was allowed to proceed until the solution was opalescent; 
it was then  stopped by the addition of lysine to a  final concentration of 0.05  M.  This was 
followed by extensive dialysis. The  KLH-anti-460-Id conjugate was then  used to immunize 
BALB/c mice according to the same schedule as that described for immunization with MOPC- 
460.  Anti-E109-Id antibodies were produced in A/He mice as previously described (1). 
Antibody Assays.  TNP-coated sheep erythrocytes (SRBC)  were prepared according to the 
technique of Rittenberg and Pratt  (4).  Levan-SRBC were prepared using O-steroyl levan as 
described  by  Hammerling  and  Westphal  (5).  MOPC-460-,  EPC-109-,  and  UPC-61-coated 
SRBC were prepared using the chromic chloride method (6). Anti-TNP, anti-levan, and anti- 
460-Id serum antibody titers were determined by agglutination of coated SRBC. The hemag- 
glutinin  (HA)  titer  reported  is  the  log2  of the  reciprocal  of the  highest  dilution  giving 
agglutination.  Serum  460-Id  titers  were  determined  by  the  capacity of serum  and  serum 
dilutions to inhibit the agglutination of MOPC-460-eoated SRBC by anti-460-Id antibodies. 
The hemagglutination inhibition titer reported is log2 of the reciprocal of the highest dilution 
of serum which caused inhibition of hemagglutination. 
Serum levels of 460-Id were also measured by a radioimmunoassay in which the capacity of 
serum and serum dilutions to inhibit the binding of 125I-labeled F(ab) fragments of MOPC-460 
by  hybridoma  anti-460-Id  antibodies was  determined  (3).  F(ab)  fragments  of MOPC-460 
myeloma protein were prepared according to the techniques of Kuetter et al. (7) and labeled 
with 12sI through the use of chloramine T  (8).  Rabbit anti-mouse Fc antibodies were used to 
precipitate complexes of MOPC-460  F(ab) fragments and anti-460-Id antibodies. These anti- 
Fc antibodies were prepared by immunization of rabbits with two injections of 1 mg each of 
purified H chains followed by absorption of the serum on an AH-Sepharose column (Pharmacia 
Fine Chemicals, Div. of Pharmacia Inc.) to which F(ab) fragments ofA/J IgG had been linked 
(9). The H  chains were purified from pooled A/J IgG by reduction and alkylation, followed by 
gel filtration on Sephadex G-200 (Pharmaeia Fine Chemicals, Div. of Pharmacia Inc.) equili- 
brated with 5 M  guanidine (10).  F(ab) fragments of A/J IgG were prepared as described by 
Porter et al. (11). 
Separation of T  and B  Lymphocytes.  Thymus-dependent  (T)  lymphocytes were  purified by 
passage over nylon wool columns. Of the cells obtained, 95-98% cguld be killed by anti-Thy 
1.2 and  complement  (C)  (12).  These cells failed to proliferate in vitro to lipopolysaccharide 
(LPS)  or NWSM.  Cell preparations enriched  in thymus-independent  (B)  lymphocytes were 
obtained by treating spleen cells with anti-Thy  1.2 serum  (Litton-Bionetics, Bethesda, Md.) 
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to concanavalin A of less than twice  background in experiments in which unseparated cells 
gave responses which were 50-120 times background. The B-cell preparations responded well 
to LPS and NWSM.  Such responses  could be abolished by treating B cells with rabbit anti- 
mouse Ig and C (13). 
In Vitro Responses to TNP-NWSM,  B lymphocytes (5  ×  105) were cultured alone or with T 
lymphocytes (5  X  105) in microtiter plates (tissue culture, cluster 36, Costar, Data Packaging, 
Cambridge, Mass.) in a modified Mishell-Dutton medium containing 10% fetal calf serum and 
10  -s M 2-mercaptoethanol in the presence or absence of TNP-NWSM (3 #g/ml) for 3 d. 
Plaque-Forming Cell (PFC) Assay.  The number of cells secreting antibodies specific for TNP 
and levan was determined by a hemolytic plaque assay, as previously described (1,  14). The 
percentage of anti-TNP PFC-secreting anti-TNP antibodies carrying the 460-Id and of anti- 
levan PFC-secreting anti-levan antibodies carrying E109-Id was determined by adding BALB/ 
c anti-460-Id or A/He anti-E109-Id antisera to the agarose, as previously described (14). The 
difference  between  the  number of PFC  obtained  in  the  absence  and  presence  of anti-Id 
represents the number of PFC-secreting antibody bearing the Id under study. The standard 
error of these numbers of PFC-secreting Id-bearing antibodies is SE --- ~/SE21 +  SE22, in which 
SE1 is the SE of the number of PFC in absence of anti-Id sera, and SE2 is the SE of the number 
of PFC in the presence of anti-Id sera. 
The number of direct  and  indirect  PFC-secreting antibody specific  for MOPC-460  was 
determined using MOPC-460-coated SRBC. 
Results 
Production of Syngeneic Anti-460oId Antibodies in BALB/c Mice.  To determine whether 
the  production  of anti-TNP  antibodies  expressing  460-Id  could  be  influenced  by 
pretreatment with anti-460-Id antibodies, or by a state of active immunity to 460-Id 
determinants, we immunized BALB/c mice with MOPC-460,  as described in Mate- 
rials and Methods.  Such mice developed antibodies which agglutinated MOPC-460- 
coated SRBC, but not MOPC-167-coated SRBC  (Table I A). Because both MOPC- 
460 and MOPC-167 are IgA, I¢-myeloma proteins, this result indicates that a syngeneic 
anti-460-Id antibody response has occurred and confirms a previous report by Sakato 
and  Eisen  (15).  Furthermore,  these  immune animals have splenic  PFC  specific for 
MOPC-460, but not for U-61 as shown by selective lysis of MOPC-460-coated SRBC 
(Table I B) and selective inhibition of this lysis by MOPC-460  (Table I C). 
Influence of Anti-460-Id Antibodies on Production of 460-Id  + Anti-TNP Antibodies.  We 
have previously shown that  a  small but significant  fraction of anti-TNP antibodies 
produced  by BALB/c  mice in  response to  immunization  with  TNP-NWSM  carry 
460-Id determinants. In the experiment illustrated in Table II, 23% of anti-TNP-PFC 
produced in response to TNP-NWSM  immunization could be inhibited by incorpo- 
ration ofanti-460-Id in the agarose, indicating that the afiti-TNP antibodies produced 
by these cells bore 460-Id.  BALB/c mice which  had been immunized with MOPC- 
460  (Id-2 mice) failed to develop any PFC which could be inhibited by anti-460-Id, 
although  they  made  a  substantial  anti-TNP  antibody  response.  Similarly,  normal 
BALB/c mice pretreated with three doses of 0.1  /~g of anti-460-Id or more failed to 
develop anti-TNP PFC which  secreted 460-Id  + antibodies.  Pretreatment  with  three 
doses of 0.01  /~g of anti-TNP-Id had  no effect. These indicate  that  modest  to high 
doses of anti-460-Id inhibit  the activation of 460-Id  + anti-TNP B cells, whereas low 
doses show neither inhibitory nor stimulatory activity. 
Production  of  Syngeneic  Antibodies  Specific for  Anti-460-Id  (Anti-[Anti-460-Id] 
Antibodies).  BALB/c mice immunized with KLH conjugates of anti-460-Id antibod- 
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TABLE  I 
Anti-ldiotypic Antibody Response to MOPC-460 by BALB/c Mice 
A.  Hemagglutinin response  (n  B.  PFC response  (n  =  5) 
=  12) 
PFC/IO  v spleen cells 
C.  Specificity of anti-460-Id PFC 
SRBC coated 
with  HA titer (log~)  SRI~C  coated with  Inhibitor 
Direct  Indirect 
Direct anti 
MOPC-460 
Amt  PFC/107 spleen 
cells 
MOPC-460  5.83 ±  0.68  MOPC-460  61.3 ±  15.5  15.8  ±  3.6  None 
MOPC-167  0  U-61  3.3  :t: 3.3  6.0 ±  2.8  MOPC-460 
U-61 
~g 
--  147  ±  9 
1  89±  7 
10  30 ±  3 
100  15  ±  4 
1  148  ±  13 
10  141  ±  1l 
|00  81  ~  13 
TABLE  II 
Number of PFC-Secreting Anti-TNP Antibodies Carrying 460-Id in Normal BALB/c Mice Injected with 
Anti-460-Id Antibodies and in Id-2 BALB/c Mice 
No. of  Anti-TNP PFC 
BALB/c mice*  Dosage  mice  Anti-TNP  Anti-MOPC 
tested  Total  460-Id  +  (HA)  460-Id (HA) 
gg  % 
Normal  --  3  305  +  15  23.0 ±  2.0  8.0  +  1.0  0.5  ±  0.5 
Id-2  --  6  245  ±  46  1.5  ±  0.9  6.5  ±  1.0  4.2  ±  0.9 
Normal pretreated  0.01  3  343  ±  17  22.0 ±  2.0  6.0  +  0  0 
With purified  0.1  3  156 ±  25  1.5  ±  1.5  7.0  ±  1.0  0 
Anti-MOPC-460-Id  1  3  118  ±  6  0  8.5  ±  0.5  0 
Antibodies  10  3  165  ±  24  14.0 ±  12.0  8.0 ±  0  3.0  ±  1.0 
100  3  244  ±  2  13.0 ±  1.0  5.0 ±  1.0  5.0  ±  2.0 
* All groups of mice were immunized with 30/Lg TNP-NWSM  7 d after completion of pretreatment. 
purified anti-460-Id  (HA titer 3.2  +  0.3)  but  not SRBC coated with BALB/c IgG2a 
or with UPC-10 myeloma protein, To determine whether these serum hemagglutinins 
were  anti-(anti-460-Id)  antibodies  or  anti-TNP  antibodies  bearing  460-Id  determi- 
nants,  we performed two types of experiments.  First, we absorbed  the putative anti- 
[anti-460-Id]  antiserum  on  TNP-KLH-Sepharose 4B  to  remove any  anti-TNP anti- 
bodies which might have been present. Such treatment did not diminish the HA titer 
on anti-460-Id-coated SRBC. Secondly, we demonstrated that the binding of 125I anti- 
460-Id hybridoma by anti-[anti-460-Id] immunoglobulin adsorbed on a plastic surface 
was not  inhibited by TNP-lysine or TNP-glycine. Buttin et al.  (3)  have shown that 
both  TNP-lysine and  TNP-glycine inhibit  the  binding  of MOPC-460  by  the  anti- 
460-Id  hybridoma.  These  results  indicate  that  the  immunoglobulins  which  can 
agglutinate anti-460-Id-coated SRBC lack anti-TNP activity. This strongly suggests 
that  these  hemagglutinins  are  anti-[anti-460-Id]  antibodies,  although  we  cannot 
entirely exclude  the  possibility  that  they  are  460-Id  +  immunoglobulins which  lack 
anti-TNP activity. 
Enhancement of the 460-Ia  ~- Component of the Anti-TNP Response  in Id-3 Mice and in Normal 
Mice  Pretreated  with  Anti-[Anti-460-Id]  Antibody.  Mice  which  had  been  immunized 
with KLH-conjugates of anti-460-Id antibodies and which developed an HA response BONA, HOOGHE,  CAZENAVE, LEGUI~RN, AND  PAUL  819 
TABLE III 
Proportion of Anti-TNP-Antibodies Carrying 460-Id in Normal BALB/c and BALB/c Mice Producing 
Anti-[Anti-460-Id] Antibodies (Id-3 Mice) 
TNP-NWSM  TNP-levan 
Normal  Id-3  Normal  Id-3 
Number of mice  5  3  5  4 
Anti-TNP PFC/106 cells  100 ±  14  84 ±  8  276 ±  15  239 ±  64 
Percent 460  ÷  27 ±  12  54 ±  5  12 ±  1  34 ±  5 
Anti-levan PFC/107 cells  ND*  ND  203 ±  130  284 -I- 41 
Percent El09  +  ND  ND  42 ±  5  45 ±  20 
Anti-TNP HA titer  6 ±  0.5  8 ±  2  12 +  0.3  12 ±  0 
460-Id HI titer  0.5 +  0.5  2 ±  1  1 -1- 0.5  3.5 +  0.5 
/tg 460-Id/ml (RL~):]:  22 ±  6  57 •  21  14 +_ 6  60 +  25 
Normal BALB/c or Id-3 BALB/c mice were immunized with 30 #g of TNP-NWSM or 50/~g of TNP- 
levan. These were sacrificed 5 d later and humoral and spleen PFC responses tested. 
* Not done. 
~: Radioimmunoassay. 
specific for anti-460-Id-coated SRBC  (Id-3 mice) were immunized with either TNP- 
NWSM or TNP-levan. These mice produced an anti-TNP antibody response in which 
the 460-Id  + component was substantially increased as compared to normal BALB/c 
mice immunized with  the  same TNP  antigens (Table III). Thus, of the  anti-TNP 
PFC  produced  by  Id-3  mice  immunized with  TNP-levan, 34%  could  be  inhibited 
with anti-460-Id, whereas only 12% of the anti-TNP PFC produced by normal BALB/ 
c  mice immunized with TNP-levan were inhibitable. The P  value for the difference 
of  these  values  was  <  0.005.  A  similar difference  was  observed  in  the  anti-TNP 
response to TNP-NWSM, although it did not reach levels of statistical significance. 
In addition, serum concentration of 460-Id molecules were also higher in Id-3 mice 
than in normal mice, as judged both by the 460-Id HI titer and by radioimmunoassay. 
On  the  other  hand,  the  total  anti-TNP  response  in  normal  and  Id-3  mice  was 
essentially the same and Id-3 mice immunized with TNP-levan displayed a proportion 
of El09  + anti-BL PFC which was similar to that of normal mice. 
Furthermore, when normal BALB/c mice were pretreated with three doses of 100 
/~g  of  an  ammonium  sulfate  fraction  of  anti-[anti-460-Id] antiserum,  previously 
absorbed on a  TNP-lysine-Sepharose-4B column, both the proportion of the 460-Id  + 
anti-TNP PFC and the serum 460-Id concentration produced in response to TNP- 
NWSM were significantly increased (Table IV). This result and that of the previous 
experiment indicate that  anti-[anti°460-Id] antibodies enhance the  number of anti- 
TNP PFC which secrete 460-Id  + antibodies. 
Absence of 460-Id-Specific  Suppressor T  Cells in  Id-3 Mice.  In a  previous study, we 
have shown that  naturally occurring 460-Id-specific suppressor T  cells regulate the 
activation of those cells potentially capable of producing 460-Id  + anti-TNP antibodies. 
In  the  following experiment,  we  compared  the  suppressive  effect  of  nylon wool- 
enriched T  lymphocytes from normal and Id-3 mice. Data presented in Table V  show 
that T  lymphocytes from normal BALB/c mice inhibited the 460-Id  + component of 
the in vitro anti-TNP response of normal and of Id-3 B lymphocytes to TNP-NWSM. 820  ANTI-ANTI-IDIOTYPE  EFFECT  ON  ANTIBODY  RESPONSE 
TABLE  IV 
Proportion of Anti-TNP Antibodies Carrying 460-Id in BALB/c Mice Pretreated  with Anti-[Anti-460- 
Id] Antibodies* 
Anti-TNP-PFC 
Pretreatment of  TNP-NWSM  N  Anti-TNP HA  gg 460-ld/ml 
Percent 460-  titer  (RIA)  mice  PFC/106 cells  id ÷ 
-  -  3  35  +  3  0  4  -4-  0.5  <0.1 
-  +  8  519  +  49  32  +  3  6.3  -  0.7  12.5  +  7.3 
+  -  3  27  +  4  43  +  8  2  4-  0.7  <0.1 
+  +  5  597  +  24  52  4-  4  7.8  +  1.1  48.5  --+  7.8 
* Mice  were  pretreated  three  times,  at  3-d  intervals, with  100  gg of an  ammonium  sulfate  fraction  of 
BALB/c  anti-[anti-460-ld]  antibodies and  immunized  1 d  after completion with  30 /tg TNP-NWSM. 
Mice  were  sacrificed  5  d  later and  humoral  and  spleen  PFC  responses  tested.  The  anti-[anti-460-Id] 
antibody used in the experimental group had been passed over a  TNP-KLH-Sepharose-4B  column. 
TABLE  V 
Proportion of PFC-Secreting Anti-TNP Antzbodies Carrying 460-Id in Cultures of T and B 
Lymphocytes from Normal and Id-3 BALB/c Mice 
Donor of lymphocytes  Anti-TNP-PFC 
460-Id + PFC/cul-  Percent 460-Id + 
B  T  PFC/culture 
ture  PFC 
Normal  --  191  +  26  73  -4-  27  38 
Normal  Normal  105  +  6  12  4-  7  11 
Normal  Id-3  134  +  13  55  +  13  41 
Id-3  --  432  +  I5  224  4-  18  52 
Id-3  Normal  440  -+  i8  42  4-  26  10 
Id-3  Id-3  367  +  41  206  4-  43  56 
B  lymphocytes (5  ×  105) were cultured alone or with 5  ×  105 T  lymphocytes in microtiter 
wells with 5  gg/ml of TNP-NWSM  for 4  d.  Anti-TNP  PFC  in  the absence or presence of 
BALB/c anti-460 antiserum (1/100 dilution) were measured using TNP-SRBC. 
By contrast, T  cells obtained from Id-3 mice failed to show any detectable inhibition 
of the 460-Id  + anti-TNP response of either normal or Id-3 B cells. This result indicates 
that Id-3 mice lack, or are deficient in, 460-Id-specific suppressor T  cells. The absence 
of such cells may be a  major factor in the heightened  460-Id  + anti-TNP  response of 
Id-3 mice. 
Discussion 
In the studies presented here, we have demonstrated that BALB/c mice with active 
or passive immunity to the idiotype(s) of MOPC-460 fail to express 460-Id + antibodies 
in  their  humoral  response  to TNP-levan  and  TNP-NWSM.  Conversely,  mice  with 
active or passive immunity to idiotypic determinants of anti-460-Id antibodies express 
a  heightened 460-Id  + component in their anti-TNP response to TNP-NWSM  and to 
TNP-levan. The mechanism through which immunity to MOPC-460-Id eliminates a 
460-Id  + response  has  not  been  established.  However,  based  on studies  in  the  phos- 
phoryl choline-T15 system and in the bacterial levan-E109 system (16, 17) elimination 
or inactivation of precursors of cells capable of secreting 460-Id  + anti-TNP antibodies 
by anti-Id antibody is a  major possibility.  In addition, in preliminary experiments we BONA, HOOGHE, CAZENAVE, LEGUERN, AND PAUL  821 
have shown that such mice possess suppressor T  lymphocytes capable of inhibiting a 
460-Id  ÷ response to TNP-NWSM but we have not yet established whether suppressor 
activity in mice actively immune to MOPC-460 exceeds that  in normal mice. The 
heightened 460-Id  + response of mice with active or passive immunity to anti-460-Id 
antibodies correlates with the absence of 460-Id-specific suppressor T  lymphocytes in 
these mice, and  is  very likely a  result of the absence of such cells.  Furthermore, it 
seems likely that anti-[anti-460-Id] antibodies have reacted with and eliminated these 
460-Id-specific suppressor T  cells, suggesting that  these suppressor T  cells and anti- 
460-Id antibody share common idiotypic determinants. This would be consistent with 
a  similarity in the structure of the 460-Id-specific receptor on the suppressor T  cell 
and of the binding site of the anti-460-Id antibody. 
Furthermore, these results suggest that the in vitro regulation by suppressor T  cells 
of the 460-Id  + component of the anti-TNP response also explains the relatively small 
component of 460-Id  + molecules in the in vivo anti-TNP response. This would suggest 
that a  regulatory network consisting of Id-bearing B cells and of T  cells specific for 
idiotype is a important feature of the normal immune response. Whether spontaneous 
development  of anti-[anti-460-Id]  antibodies  and  T  cells  also  occurs  and  acts  to 
regulate the natural level of suppression is a provocative but unresolved issue. 
Other instances in which an idiotype-anti-idiotype network has been employed to 
explore the  role of such  a  mechanism  in  regulation  should  be  mentioned.  In  one 
striking example, rabbit anti-Id antibody to anti-ribonuclease obtained from a single 
donor was  prepared.  Rabbits  immunized  to these anti-Id  antibodies  and  then  im- 
munized with ribonuclease developed anti-ribonuclease antibodies with an idiotype 
similar to that expressed by the antibodies used to prepare the initial anti-Id antibody. 
Because sharing of idiotypes in anti-ribonuclease antibodies of normal rabbits is rarely 
observed (18), these results suggest that immunization with anti-Id antibody perturbed 
the  existing  balance,  either  by  directly  activating  Id-bearing  B  or  T  cells  or  by 
eliminating suppressor T  cells which normally limited the expression of that idiotype. 
A similar observation has been made in response to certain polysaccharide antigens 
(19). 
These  examples  and  our  results  give  clear  illustrations  of the  ways  in  which 
regulatory interactions among a network (20) of Id-bearing and Id-specific antibodies 
and cells might occur~ as well as emphasizing that second degree idiotype-anti-idiotype 
(Id-2-anti-Id-2) interactions could profoundly effect the expression of Id-I (e.g., 460- 
Id  +  anti-TNP  antibodies)  determinants  on  the  antibodies  produced  as  a  result  of 
conventional immunization. The extent to which anti-[anti-460-Id] antibodies occur 
and  to which anti-460-Id T  cells are eliminated in normal strains  immunized with 
TNP-NWSM  or TNP-levan would shed considerable light on the physiologic rele- 
vance of these systems. 
Summary 
The antibody response of BALB/c mice to trinitrophenyl  (TNP)-levan or TNP- 
Nocardia water-soluble mitogen (NWSM) includes a small but significant fraction of 
antibodies  which  share  idiotypes  (Id)  with  the  dinitrophenyl  (DNP)-  and  TNP- 
binding myeloma protein MOPC-460.  Active immunization of BALB/c mice with 
MOPC-460  or passive administration  of anti-460-Id antibodies suppresses  the 460- 
Id  + component of the anti-TNP response. By contrast, active immunization of BALB/ 822  ANTI-ANTI-IDIOTYPE EFFECT  ON ANTIBODY  RESPONSE 
c with anti-460-Id antibodies or passive administration  of BALB/c anti-[anti-460-Id] 
antibodies  leads  to  an  enhanced  460-Id  ÷  component  in  the  anti-TNP  antibodies 
produced in response to TNP-levan or TNP-NWSM. This enhanced 460-Id  + response 
appears to be a  result of the elimination of suppressor T  lymphocytes specific for the 
460-Id as T  lymphocytes from such mice are unable to suppress the in vitro 460-Id  + 
response  to  TNP-NWSM  whereas  normal  T  cells  are  suppressive.  These  results 
indicate  that  suppressor  cells specific for 460-Id normally regulate  the  activation  of 
precursors of cells capable of secreting 460-Id  + anti-TNP antibodies. 
We thank Mrs. Shirley House for expert technical assistance. 
Received  for publication 18 December 1978. 
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